Clinical Trial Update: Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gilteritinib plus VA (venetoclax and azacitidine) followed by consolidation chemotherapy in newly diagnosed FLT3-ITD positive acute mye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Gilteritinib (gilteritinib)
• Venetoclax (venetoclax)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Acute Myeloid Leukemia, FLT3 Internal Tandem Duplication Positive | Phase 2 | Status: RECRUITING